JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
Inogen
INGN
$153M
| $497K | ﹤0.01% |
39,763
+2,846
| +8% | +$54.5K |
|
|
JAMF
4302
DELISTED
Jamf
JAMF
| $496K | ﹤0.01% |
25,521
+3,778
| +17% | +$75.7K |
|
|
PNT
4303
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $496K | ﹤0.01% |
68,242
-57,004
| -46% | -$423K |
|
4304
Anavex Life Sciences
AVXL
$298M
| $495K | ﹤0.01% |
57,722
+13,748
| +31% | +$137K |
|
4305
Alerian Energy Infrastructure ETF
ENFR
$528M
| $494K | ﹤0.01% |
+23,611
| New | +$505K |
|
4306
First Internet Bancorp
INBK
$254M
| $494K | ﹤0.01% |
29,719
-71,984
| -71% | -$1.74M |
|
|
NPKI
4307
NPK International
NPKI
$1.21B
| $494K | ﹤0.01% |
128,266
-100,095
| -44% | -$438K |
|
4308
Xponential Fitness
XPOF
$206M
| $493K | ﹤0.01% |
16,220
+5,776
| +55% | +$153K |
|
4309
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $492K | ﹤0.01% |
3,800
| – | – |
|
|
4310
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $492K | ﹤0.01% |
3,800
-213,500
| -98% | -$27.9M |
|
4311
PubMatic
PUBM
$801M
| $491K | ﹤0.01% |
35,565
+9,363
| +36% | +$135K |
|
4312
Cadre Holdings
CDRE
$1.46B
| $491K | ﹤0.01% |
22,783
+4,883
| +27% | +$106K |
|
4313
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $489K | ﹤0.01% |
7,574
-2,206
| -23% | -$138K |
|
|
IMTXW
4314
DELISTED
Immatics N.V. Warrants
IMTXW
| – | – |
0
| – | – |
|
4315
Invesco KBW High Dividend Yield Financial ETF
KBWD
$431M
| $487K | ﹤0.01% |
33,026
+2,595
| +9% | +$41.2K |
|
|
MLNK
4316
DELISTED
MeridianLink
MLNK
| $487K | ﹤0.01% |
28,157
+5,348
| +23% | +$86.1K |
|
4317
PUT
Accenture
ACN
$108B
| $486K | ﹤0.01% |
1,700
-36,700
| -96% | -$10M |
|
4318
Vera Bradley
VRA
$93M
| $483K | ﹤0.01% |
80,701
+30,627
| +61% | +$171K |
|
4319
Ducommun
DCO
$3.13B
| $482K | ﹤0.01% |
8,804
+1,315
| +18% | +$71.7K |
|
4320
Broadwind
BWEN
$127M
| $480K | ﹤0.01% |
+124,887
| New | +$532K |
|
4321
Gevo
GEVO
$418M
| $480K | ﹤0.01% |
311,755
+50,680
| +19% | +$96K |
|
4322
First Trust Technology AlphaDEX Fund
FXL
$2.88B
| $479K | ﹤0.01% |
4,550
+1,999
| +78% | +$202K |
|
4323
Barrett Business Services
BBSI
$781M
| $478K | ﹤0.01% |
21,580
-1,300,284
| -98% | -$30.4M |
|
4324
Aptus Enhanced Yield ETF
JUCY
$328M
| $478K | ﹤0.01% |
+19,174
| New | +$481K |
|
4325
Mitsubishi UFJ Financial
MUFG
$260B
| $476K | ﹤0.01% |
74,652
+14,745
| +25% | +$103K |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.